Apeiron Biologics and Columbia University sign exclusive license agreement
To develop and commercialise active cellular immunotherapies under licensed patents, which cover inhibition of Cbl-b in T cells…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.